← Back to Search

ConcenTrace for Gut Health

N/A
Recruiting
Research Sponsored by Trace Minerals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This trial tests the effectiveness of drops for gut health over 12 weeks with surveys and evaluations on regularity, constipation, bloating, and more. Results will be presented as percentage scores.

Who is the study for?
This trial is for men and women over 18 with a BMI under 35 who experience digestive issues like heartburn, gas, or constipation. Participants should be generally healthy without any uncontrolled diseases and willing to keep their diet, activity level, and weight stable during the study.Check my eligibility
What is being tested?
The trial is testing ConcenTrace Trace Mineral Drops' effects on gut health over a period of 12 weeks. Participants will take the drops daily and report on various aspects of gut health including bowel movements and bloating at multiple points throughout the study.See study design
What are the potential side effects?
Potential side effects are not explicitly listed but may include changes in digestion or bowel habits due to mineral intake from the drops. Any adverse reactions experienced by participants will likely be monitored through questionnaires.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in scores on the Gastrointestinal Symptom Rating Scale (GSRS). [Timeframe: Baseline to Week 12]
Secondary outcome measures
Changes in bowel movement frequency. [Timeframe: Baseline to Week 12]
Changes in stool consistency reported via the Bristol Stool Chart. [Timeframe: Baseline to Week 12]

Trial Design

1Treatment groups
Experimental Treatment
Group I: Test arm: ConcenTraceExperimental Treatment1 Intervention
Participants will follow this weekly dosing schedule: Week 1: Day 1-3: take 5 drops of ConcenTrace with 8oz of water or flavored water. Day 4-7: take 5 drops of ConcenTrace 2x per day with 8 oz of water or flavored water. Week 2: Take 10 drops of ConcenTrace 2x per day with 8 oz of water or flavored water. Week 3: Take 15 drops of ConcenTrace 2x per day with 8 oz of water or flavored water. Week 4: Take 20 drops of ConcenTrace 2x per day with 8 oz of water or flavored water. Weeks 5 - 12: Take 40 drops of ConcenTrace 1x per day with 8 oz of water or flavored water.

Find a Location

Who is running the clinical trial?

Trace MineralsLead Sponsor
1 Previous Clinical Trials
40 Total Patients Enrolled
CitruslabsIndustry Sponsor
68 Previous Clinical Trials
3,805 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still openings for participants in this investigation?

"The clinicaltrial.gov registry shows that this research study is actively recruiting participants - the trial was posted on October 5th 2023 and last updated on November 2nd of the same year."

Answered by AI

What is the cap of participants for this scientific exploration?

"Affirmative, information on clinicaltrials.gov confirms that recruitment for this trial is ongoing. The original post was made on October 5th 2023 and the details of the study were last refreshed on November 2nd 2023. A total of 40 patients must be recruited from 1 medical centre."

Answered by AI
~27 spots leftby Apr 2025